Cargando…
Evaluation of metformin in combination with rifampicin containing antituberculosis therapy in patients with new, smear-positive pulmonary tuberculosis (METRIF): study protocol for a randomised clinical trial
INTRODUCTION: Shorter duration of treatment for the management of drug-susceptible pulmonary tuberculosis (TB) would be a significant improvement in the care of patients suffering from the disease. Besides newer drugs and regimens, other modalities like host-directed therapy are also being suggested...
Autores principales: | Padmapriyadarsini, Chandrasekaran, Bhavani, Perumal K, Natrajan, Mohan, Ponnuraja, Chinnayan, Kumar, Hemanth, Gomathy, Sivaramakrishnan N, Guleria, Randeep, Jawahar, Shaheed M, Singh, Manjula, Balganesh, Tanjore, Swaminathan, Soumya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429929/ https://www.ncbi.nlm.nih.gov/pubmed/30826761 http://dx.doi.org/10.1136/bmjopen-2018-024363 |
Ejemplares similares
-
Randomised trial to evaluate the effectiveness and safety of varying doses of linezolid with bedaquiline and pretomanid in adults with pre-extensively drug-resistant or treatment intolerant/non-responsive multidrug-resistant pulmonary tuberculosis: study protocol
por: Padmapriyadarsini, Chandrasekaran, et al.
Publicado: (2022) -
Predictors of unfavorable responses to therapy in rifampicin-sensitive pulmonary tuberculosis using an integrated approach of radiological presentation and sputum mycobacterial burden
por: Gopalan, Narendran, et al.
Publicado: (2021) -
Randomized Trial of Metformin With Anti-Tuberculosis Drugs for Early Sputum Conversion in Adults With Pulmonary Tuberculosis
por: Padmapriydarsini, Chandrasekaran, et al.
Publicado: (2021) -
Suboptimal Antituberculosis Drug Concentrations and Outcomes in Small and HIV‐Coinfected Children in India: Recommendations for Dose Modifications
por: Guiastrennec, Benjamin, et al.
Publicado: (2018) -
Drug susceptibility profiling of pulmonary Mycobacterium kansasii and its correlation with treatment outcome
por: Rajendran, Priya, et al.
Publicado: (2021)